Primary platelet aggregation. Energy metabolism and the effect of inhibitors.
D000225:Adenine / Q000378:metabolism; D000241:Adenosine / Q000494:pharmacology; D000244:Adenosine Diphosphate / Q000378:metabolism / Q000494:pharmacology; D000255:Adenosine Triphosphate / Q000378:metabolism; D000963:Antimetabolites / Q000494:pharmacology; D001792:Blood Platelets / Q000187:drug effects / Q000378:metabolism*; D002729:Chloromercuribenzoates / Q000494:pharmacology; D003078:Colchicine / Q000494:pharmacology; D003486:Cyanides / Q000494:pharmacology; D004492:Edetic Acid / Q000494:pharmacology; D004837:Epinephrine / Q000494:pharmacology; D006801:Humans; D006851:Hydrochloric Acid / Q000494:pharmacology; D006863:Hydrogen-Ion Concentration; D007292:Inosine Nucleotides / Q000378:metabolism; D008012:Lidocaine / Q000494:pharmacology; D008628:Mercury; D009942:Organometallic Compounds / Q000494:pharmacology; D010973:Platelet Adhesiveness; D010974:Platelet Aggregation / Q000187:drug effects; D011453:Prostaglandins / Q000494:pharmacology; D012701:Serotonin / Q000494:pharmacology; D013451:Sulfonic Acids / Q000494:pharmacology; D013997:Time Factors; D014105:Tosyl Compounds / Q000494:pharmacology; D014316:Tritium; D014667:Vasopressins / Q000494:pharmacology
D000963:Antimetabolites; D002729:Chloromercuribenzoates; D003486:Cyanides; D007292:Inosine Nucleotides; D009942:Organometallic Compounds; D011453:Prostaglandins; D013451:Sulfonic Acids; D014105:Tosyl Compounds; D014316:Tritium; D014667:Vasopressins; D012701:Serotonin; D000244:Adenosine Diphosphate; D000255:Adenosine Triphosphate; D008012:Lidocaine; D004492:Edetic Acid; D008628:Mercury; D000225:Adenine; D000241:Adenosine; D006851:Hydrochloric Acid; D003078:Colchicine; D004837:Epinephrine